TNFRSF9 and breast carcinoma: Gene expression analyses further reveal elevated levels of classic brown (MYF5, EVA1, OPLAH) and beige (CD137/TNFRSF9, TBX1) adipocyte markers, along with PRDM16-a key regulator of brown adipocyte differentiation-in breast cancer xenografts [12–14].